• 1. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 2. Estimation of fusel-oil in spirits
  Analyst, 1890,15, 203-209
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines N-alkylpyrrolidines

Recent Advances in the Study of (3R)-1-(oxetan-3-yl)pyrrolidin-3-amine (CAS: 1256667-56-7) in Chemical Biology and Pharmaceutical Research

The compound (3R)-1-(oxetan-3-yl)pyrrolidin-3-amine (CAS: 1256667-56-7) has recently emerged as a promising scaffold in chemical biology and pharmaceutical research. This molecule, characterized by its oxetane and pyrrolidine moieties, has attracted significant attention due to its potential applications in drug discovery, particularly in the development of novel therapeutics targeting central nervous system (CNS) disorders and infectious diseases. Recent studies have explored its synthetic accessibility, pharmacokinetic properties, and biological activities, positioning it as a versatile building block for medicinal chemistry.

One of the key findings in recent literature is the role of (3R)-1-(oxetan-3-yl)pyrrolidin-3-amine as a precursor in the synthesis of small-molecule inhibitors targeting enzymes such as kinases and proteases. Researchers have demonstrated that the oxetane ring enhances the metabolic stability of the compound while maintaining favorable solubility profiles. Additionally, the stereochemistry at the 3-position of the pyrrolidine ring has been shown to significantly influence binding affinity to biological targets, underscoring the importance of enantiomeric purity in its applications.

In a 2023 study published in the Journal of Medicinal Chemistry, (3R)-1-(oxetan-3-yl)pyrrolidin-3-amine was utilized as a key intermediate in the development of a new class of antiviral agents. The study highlighted its ability to improve the bioavailability of lead compounds through strategic modifications of its amine functionality. Furthermore, computational modeling and X-ray crystallography data revealed that the oxetane ring engages in unique hydrogen-bonding interactions with target proteins, providing insights for structure-based drug design.

Another significant advancement involves the application of this compound in the field of neuropharmacology. Preclinical studies have shown that derivatives of (3R)-1-(oxetan-3-yl)pyrrolidin-3-amine exhibit potent activity as modulators of neurotransmitter receptors, particularly those involved in dopamine and serotonin signaling. These findings suggest potential therapeutic avenues for treating psychiatric and neurodegenerative disorders, although further in vivo validation is required to assess efficacy and safety.

From a synthetic chemistry perspective, recent efforts have focused on optimizing the production of (3R)-1-(oxetan-3-yl)pyrrolidin-3-amine to meet the growing demand for high-purity material. Innovations in catalytic asymmetric synthesis and flow chemistry have enabled scalable and cost-effective manufacturing processes, addressing previous challenges related to yield and enantioselectivity. These advancements are expected to facilitate broader adoption of this compound in both academic and industrial research settings.

In conclusion, (3R)-1-(oxetan-3-yl)pyrrolidin-3-amine (CAS: 1256667-56-7) represents a valuable tool in modern drug discovery, with demonstrated utility across multiple therapeutic areas. Its unique structural features and favorable physicochemical properties make it an attractive candidate for further exploration. Future research directions may include the development of novel derivatives with enhanced selectivity and the investigation of its potential in combination therapies. As the field progresses, this compound is likely to play an increasingly important role in addressing unmet medical needs.

• 1256667-60-3((3S)-1-(oxetan-3-yl)pyrrolidin-3-amine)
• 53617-37-1(4-(Pyrrolidin-3-yl)morpholine)
• 216667-74-2((3S)-1-(2-methoxyethyl)-3-Pyrrolidinamine)
• 216669-67-9(Morpholine,4-(3S)-3-pyrrolidinyl-)
• 1228674-21-2(2-(Methoxymethyl)-1-pyrrolidin-3-ylpyrrolidine)
• 1349699-66-6((3S)-1-(oxetan-3-yl)piperidin-3-amine)
• 1096335-57-7(1-(2-Methoxyethyl)pyrrolidin-3-amine)
• 511295-94-6(Morpholine,4-(3R)-3-pyrrolidinyl-)
• 546114-80-1(2-PYRROLIDINEMETHANAMINE, N-ETHYL-1-(2-METHOXYETHYL)-, (2S)-)
• 1349700-06-6((3R)-1-(oxetan-3-yl)piperidin-3-amine)